Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGS2 | P35354 | 18/20 | 0.49 |
| ▸ | PTGS1 | P23219 | 9/20 | 0.49 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | MT-CO2 | P00403 | 1/20 | 0.49 |
| ▸ | HTR1A | P08908 | 1/20 | 0.49 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.49 |
| ▸ | MC4R | P32245 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13492165 | 0.78 | PTGS1 (0.41) | PTGS2PTGS1ALDH1A1 | |
| SCHEMBL17073804 | 0.74 | NPC1 (0.43) | PTGS2PTGS1ABCB11ALDH1A1MT-CO2 | |
| SCHEMBL3215846 | 0.74 | PTGS1 (0.43) | PTGS2PTGS1 | |
| SCHEMBL13923616 | 0.74 | ALDH1A1 (0.40) | PTGS2ALDH1A1MT-CO2 | |
| SCHEMBL13492167 | 0.74 | HTR2C (0.36) | ALDH1A1 | |
| SCHEMBL30692648 | 0.74 | CA1 (0.48) | PTGS1ALDH1A1 | |
| SCHEMBL7618292 | 0.74 | PTGS2 (0.42) | PTGS2PTGS1ALDH1A1 | |
| SCHEMBL979881 | 0.74 | KMT2A (0.45) | PTGS2PTGS1ALDH1A1 | |
| SCHEMBL7653063 | 0.72 | PTGS2 (0.49) | PTGS2PTGS1ABCB11ALDH1A1MT-CO2 | |
| SCHEMBL2165399 | 0.71 | MAPT (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1890729-A2 | USE OF CAROTENOIDS AND/OR CAROTENOID DERIVATIVES/ANALOGS FOR REDUCTION/INHIBITION OF CERTAIN NEGATIVE EFFECTS OF COX INHIBITORS | Cardax Pharmaceuticals, Inc. (US) | 2008-02-27 | — | — | EP | disclosed |
| EP-1881986-A2 | TYROSINE KINASE INHIBITORS | Merck & Co., Inc. (US) | 2008-01-30 | — | — | EP | disclosed |
| WO-2007129169-A2 | COX- II INHIBITORS FOR IMPROVING REPRODUCTIVE SUCCESS IN A FEMALE ANIMAL | PFIZER LIMITED (GB) | 2007-11-15 | — | — | WO | disclosed |
| WO-2006124354-A2 | TYROSINE KINASE INHIBITORS | MERCK & CO., INC. (US) | 2006-11-23 | — | — | WO | disclosed |
| WO-2006119168-A2 | USE OF CAROTENOIDS AND/OR CAROTENOID DERIVATIVES/ANALOGS FOR REDUCTION/INHIBITION OF CERTAIN NEGATIVE EFFECTS OF COX INHIBITORS | CARDAX PHARMACEUTICALS, INC. (US) | 2006-11-09 | — | — | WO | disclosed |
| WO-2006020850-A2 | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS | MYRIAD GENETICS, INC. (US) | 2006-02-23 | — | — | WO | disclosed |
| WO-2006020852-A2 | PHARMACEUTICAL COMPOSITION AND METHOD FOR TREATING NEURODEGENERATIVE DISORDERS | MYRIAD GENETICS, INC. (US) | 2006-02-23 | — | — | WO | disclosed |
| WO-2004028456-A2 | METHOD AND COMPOSITION FOR TREATING NEURODEGENERATIVE DISORDERS | MYRIAD GENETICS, INC (US) | 2004-04-08 | — | — | WO | disclosed |
| EP-1299123-A2 | USE OF COX-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF OCULAR COX-2 MEDIATED DISORDERS | Pharmacia Corporation (US) | 2003-04-09 | — | — | EP | disclosed |
| WO-2002005848-A2 | USE OF COX-2 INHIBITORS IN THE TREATMENT AND PREVENTION OF OCULAR COX-2 MEDIATED DISORDERS | PHARMACIA CORPORATION (US) | 2002-01-24 | — | — | WO | disclosed |